You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 202009230039417e505fc6
conjunctiva
Oops, an error occurred! Code: 2020092300394133114136
disease gene mapping
Oops, an error occurred! Code: 20200923003941c772a5ab
gene/expression
Oops, an error occurred! Code: 20200923003941a52361bf
gene microarray
Oops, an error occurred! Code: 20200923003941a24d279e
genetics
Oops, an error occurred! Code: 2020092300394179b74c96
immunohistochemistry
Oops, an error occurred! Code: 20200923003941f6537907
iris
Oops, an error occurred! Code: 20200923003941c2ef9c21
melanoma
Oops, an error occurred! Code: 20200923003941c80e6611
oncology
Oops, an error occurred! Code: 20200923003941d2ceab13
pathology: experimental
Oops, an error occurred! Code: 2020092300394155c157e8
pathology: human
Oops, an error occurred! Code: 202009230039413ecd66c6
pathology techniques
Oops, an error occurred! Code: 20200923003941036186f4
tumors
Oops, an error occurred! Code: 20200923003941fe117bd3
uvea
Oops, an error occurred! Code: 2020092300394128148571
vision and action
Oops, an error occurred! Code: 2020092300394140205172
visual acuity
Oops, an error occurred! Code: 20200923003941b43baf52
uveal melanoma
Oops, an error occurred! Code: 202009230039416addbddc
conjunctival melanoma
Oops, an error occurred! Code: 20200923003941f2937d1d
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 202009230039411e1dc928
pathology
Oops, an error occurred! Code: 20200923003941c96be6ab
translational studies
Oops, an error occurred! Code: 202009230039416f40d7f1